TB Vaccine PreClinical Pipeline

This Pipeline provides information on vaccine candidates in preclinical development. Click here to view candidates in clinical development. Click on the candidate name for more detailed information. To filter vaccine candidates by platform, target indication, target population, animal models, and immunological information, click on the "Sortable Pipeline button" button.

For more information about this Pipeline, please review the Terms of the TB Vaccine Pipeline.

If you would like to submit a vaccine candidate for inclusion in the pipeline or update information for a vaccine candidate, please fill out the TB vaccine candidate submission form.

Proof of Concept – Animal Model

BCG, ChadOx/MVA 5Ag

Univ Oxford


St George's Univ London, Sporegen LTD


Tulane Univ & Texas Biomed Res Inst, NIH, BMGF




James Cook Univ.

BCG w/MK-2206

Institut Pasteur de Tunis, THSTI

Spray Dried ID93+GLA-SE


Prep for
Phase 1

No current candidates

The Preclinical Pipeline includes TB vaccine candidates that have been submitted to WGNV by the vaccine developer. It is not exhaustive. To submit a TB vaccine candidate for inclusion in this Pipeline, please submit a Preclinical Candidate Submission Form.

Pipeline updated 15 May 2024
Click on an individual candidate to see when it was last updated


The TB Vaccine Pipeline (“Pipeline”) is provided for informational purposes. The information used in this Pipeline (“Information”) was reported by the sponsor/lead developer or found in the public domain associated with the specific candidate and should be considered “as is.” The Stop TB Partnership Working Group on New TB Vaccines does not guarantee or warrant the accuracy, completeness, or reliability of any of the Information displayed in this Pipeline. Use of any such Information, for whatever purpose, shall be at the user’s own risk and liability.